EMJ Innovations 9 [Supplement 1] . 2025

In this issue

In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient with faricimab resulted in several benefits, including timely treatment, reduced treatment burden for patients and caregivers, reduced frequency and cost of out-of-hours services, and freed up clinic staff to manage waiting lists in other ophthalmology services.